Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer. Pizurica M, Larmuseau M, Van der Eecken K, de Schaetzen van Brienen L, et al. Cancer Res 2023 Jun 23:CAN-22-3113. doi: 10.1158/0008-5472.CAN-22-3113.

Read + Share

Amedeo Smart

Independent Medical Education

Pizurica M, Larmuseau M, Van der Eecken K, de Schaetzen van Brienen L, et al. Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer. Cancer Res 2023 Jun 23:CAN-22-3113. doi: 10.1158/0008-5472.CAN-22-3113.
PMID: 37352385